Physician profile
Eric J Dahl
NPI 1114140811
$382.54
in general payments reported to CMS, 2019-2025
8 companies · $20.92 in 2025
The $20.92 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.77 · 2021: $40.10 · 2022: $16.36 · 2023: $48.02 · 2024: $175 · 2025: $20.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.31 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.18 | 2024-2025 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $105.89 | 2019-2023 | Eliquis |
| Gilead Sciences, INC. | $67.11 | 2024 | |
| Alexion Pharmaceuticals, INC. | $27.40 | 2019-2022 | |
| Pfizer INC. | $20.43 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Allergan, INC. | $19.16 | 2019 | |
| Genentech USA, INC. | $13.37 | 2023 | Activase |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Dahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.